10x Genomics Inc is a life science technology company ... and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes ...

Genomics, Inc. (NASDAQ:TXG – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

and streamline your search for investment opportunities using Tipranks' Stock Screener Daniel Arias has given his Buy rating due to a combination of factors that highlight 10x Genomics’s strong ...

10x Genomics excels in single-cell and spatial technologies but faces significant challenges. Despite an EPS beat, revenue fell 1% due to sales disruption and competitive pricing. The company's ...

Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.

10x Genomics stock tumbled 24.7% to 15.67. Shares hit a record low at 14.02. 10x sells systems capable of performing spatial ...

10x Genomics uses filings with the Securities and ... conferences and advertising on our websites and newsletters. How we use your information depends on the product and service that you use ...

EST Cathie Wood’s ARK Investment buys 247K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...

using or offering to sell in the United States its GeoMx digital spatial profiler and associated instruments for RNA and protein detection, the company added. 10x Genomics also said the court ...

10x Genomics, Inc. is providing these updates in ... Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should ...